An autoimmune disease-associated risk variant in the TNFAIP3 gene plays a protective role 1 in brucellosis that is mediated by the NF-kappa B signaling pathway 2

12 occurring (rs148314165 In this analysis, we conducted a genetic association study of the TT>A variants in 1209 controls 16 and in 150 patients with brucellosis, an infectious disease, and further assessed the role of the 17 variants in brucellosis. Our data demonstrated that the TT>A variants were correlated with cases 18 of brucellosis ( P = 0.002, OR = 0.34) and with individuals who had a positive serum 19 agglutination test (SAT > 1/160) ( P = 4.2 × 10 -6 , OR = 0.23). A functional study demonstrated 20 that brucellosis patients carrying the protective allele (A) showed significantly lower expression 21 of the TNFAIP3 gene in their peripheral blood mononuclear cells and showed increased NF-κB 22 signaling. Monocytes from individuals carrying the A allele that were stimulated with B. abortus 23 had lower mRNA levels of TNFAIP3 and produced more IL-10, IL-6, and IL-1β than those from 24 TT allele carriers. These data showed that the autoimmune disease-associated risk variants, 25 TT>A, of the TNFAIP3 locus play a protective role in the pathogenesis of brucellosis. Our findings suggest that disruption of the normal function of the TNFAIP3 gene might serve as a 27 therapeutic target for the treatment of brucellosis. in which the TT>A variants are found binds to NF-κB transcription factors p50, p65, and and delivers them to the promoter region of the TNFAIP3 gene, activating transcription in multiple types of cells. The SLE-associated risk A allele disrupts the binding of NF-κB transcription factors and significantly reduces the expression of TNFAIP3 . In our published study, we also showed that TALEN-mediated TT>A-enhancer leads to reduced expression of TNFAIP3 and significant increases in NF-κB signaling activity These have positioned the TT>A variants as NF-κB signaling modifiers, and they might play a role in infectious diseases. As shown in this study, the SLE-associated risk allele was significantly associated with a decreased risk of brucellosis. cytokines The TT>A functional variants to reduced expression of TNFAIP3 and enhanced NF-κB predisposes individuals to autoimmune diseases while protecting them from brucellosis. We therefore assessed the role of TT>A variants in regulating the gene expression of multiple cytokines. Our data showed that increased activity of NF-κB in monocytes results in a

[1]  D. Ye,et al.  Associations between TNFAIP3 gene polymorphisms and systemic lupus erythematosus risk: an updated meta‐analysis , 2016, HLA.

[2]  Mai Moaaz,et al.  Association of the polymorphisms of TRAF1 (rs10818488) and TNFAIP3 (rs2230926) with rheumatoid arthritis and systemic lupus erythematosus and their relationship to disease activity among Egyptian patients , 2016, Central-European journal of immunology.

[3]  W. El-Baz,et al.  CD28 and PTPN22 are associated with susceptibility to rheumatoid arthritis in Egyptians. , 2016, Human immunology.

[4]  P. Gaffney,et al.  TALEN-mediated enhancer knockout influences TNFAIP3 gene expression and mimics a molecular phenotype associated with systemic lupus erythematosus , 2016, Genes and Immunity.

[5]  Xu Wang,et al.  Characteristics of A20 gene polymorphisms and clinical significance in patients with rheumatoid arthritis , 2015, Journal of Translational Medicine.

[6]  Yasong Li,et al.  TNFAIP3 rs2230926 polymorphisms in rheumatoid arthritis of southern Chinese Han population: a case-control study. , 2014, International journal of clinical and experimental pathology.

[7]  門田 景介 Analysis of gender differences in genetic risk : association of TNFAIP3 polymorphism with male childhood-onset systemic lupus erythematosus in the Japanese population , 2014 .

[8]  C. Dinarello,et al.  Treating inflammation by blocking interleukin-1 in humans. , 2013, Seminars in immunology.

[9]  P. Gaffney,et al.  An Enhancer Element Harboring Variants Associated with Systemic Lupus Erythematosus Engages the TNFAIP3 Promoter to Influence A20 Expression , 2013, PLoS genetics.

[10]  S. Bae,et al.  Pathway analysis of genome-wide association studies on rheumatoid arthritis. , 2013, Clinical and experimental rheumatology.

[11]  鈴木 拓 PADI4 and HLA-DRB1 are genetic risks for radiographic progression in RA patients, independent of ACPA status : results from the IORRA cohort study(本文) , 2013 .

[12]  A. Ma,et al.  A20: linking a complex regulator of ubiquitylation to immunity and human disease , 2012, Nature Reviews Immunology.

[13]  S. Bae,et al.  Associations between TNFAIP3 gene polymorphisms and rheumatoid arthritis: a meta-analysis , 2012, Inflammation Research.

[14]  Debashis Ghosh,et al.  Proinflammatory Caspase-2-Mediated Macrophage Cell Death Induced by a Rough Attenuated Brucella suis Strain , 2011, Infection and Immunity.

[15]  D. Ye,et al.  The association between BANK1 and TNFAIP3 gene polymorphisms and systemic lupus erythematosus: a meta‐analysis , 2011, International journal of immunogenetics.

[16]  G. Pappas,et al.  Cell-mediated immunity in human brucellosis. , 2011, Microbes and infection.

[17]  A. Kawasaki,et al.  Association of TNFAIP3 Polymorphism with Susceptibility to Systemic Lupus Erythematosus in a Japanese Population , 2010, Journal of biomedicine & biotechnology.

[18]  A. De La Hera,et al.  Human Brucellosis Is Characterized by an Intense Th1 Profile Associated with a Defective Monocyte Function , 2010, Infection and Immunity.

[19]  Yusuke Nakamura,et al.  The association of a nonsynonymous single-nucleotide polymorphism in TNFAIP3 with systemic lupus erythematosus and rheumatoid arthritis in the Japanese population. , 2010, Arthritis and rheumatism.

[20]  I. Baydar,et al.  TNF-alpha, TGF-beta, IL-10, IL-6 and IFN-gamma gene polymorphisms as risk factors for brucellosis. , 2009, The new microbiologica.

[21]  Pui-Yan Kwok,et al.  Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus , 2008, Nature Genetics.

[22]  S. Oliveira,et al.  The role of innate immune receptors in the control of Brucella abortus infection: toll-like receptors and beyond. , 2008, Microbes and infection.

[23]  C. Guzmán-Verri,et al.  Brucella abortus Uses a Stealthy Strategy to Avoid Activation of the Innate Immune System during the Onset of Infection , 2007, PloS one.

[24]  R. Goenka,et al.  Host immune responses to the intracellular bacteria Brucella: does the bacteria instruct the host to facilitate chronic infection? , 2006, Critical reviews in immunology.

[25]  M. J. Bravo,et al.  Polymorphisms of the interferon gamma and interleukin 10 genes in human brucellosis. , 2003, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[26]  J. Oliaro,et al.  The innate immune response against Brucella in humans. , 2002, Veterinary microbiology.

[27]  Ashok Kumar,et al.  Nef Protein of Human Immunodeficiency Virus and Lipopolysaccharide Induce Expression of CD14 on Human Monocytes through Differential Utilization of Interleukin-10 , 2002, Clinical and Vaccine Immunology.

[28]  D. Scott,et al.  Immunity and protection against Brucella abortus. , 2001, Microbes and infection.

[29]  R. Beyaert,et al.  A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappa B-dependent gene expression and apoptosis. , 2000, Biochemical pharmacology.

[30]  A. Kelso,et al.  Differential activation of Brucella-reactive CD4+ T cells by Brucella infection or immunization with antigenic extracts , 1995, Infection and immunity.